NCT02663713View on ClinicalTrials.gov

A Randomized, Pharmacodynamic Comparison of Low Dose Ticagrelor to Clopidogrel in Patients With Prior Myocardial Infarction

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions
Myocardial InfarctionDiabetes MellitusRenal DiseaseCoronary Artery Disease
Interventions
DRUG

Ticagrelor

Ticagrelor 60mg twice daily

DRUG

Clopidogrel

Clopidogrel 75 mg once daily

Trial Locations (1)

26500

Cardiology Department Patras University Hospital, Rio

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

University of Patras

OTHER